Molecular diagnosis and Capripoxvirus confirmation
Suspected field samples consisting of skin biopsies and scabs were processed for DNA isolation and subjected to PCR analysis (Table 1). Amplification of
Capripoxvirus P32 gene encoding was carried out for- Standard virus (Sheeppox vaccine virus); Tissue lysates prepared from cutaneous scabs containing putative
Sheeppoxvirus (SPPV); Tissue lysates prepared from cutaneous scabs containing putative
Goatpoxvirus (GTPV); Lysates prepared from putative GTPV inoculated on chicken embryonated egg CAM. Positive samples amplified an expected amplicon size of 192 bp PCR product (Fig 1A, B).
Molecular characterization of different Capripoxviruses
After purification of the PCR products, one product from sheep origin (
Sheeppoxvirus isolated in Surinsar area of Jammu district) and another of goat origin (
Goatpoxvirus isolated in Akhnoor area of Jammu district) were commercially sequenced, annotated and submitted to Genbank, NCBI with published accession numbers (MK358827 and MK358828 respectively).
Phylogenetic analysis of different Capripoxviruses
Sequence comparison showed that
Capripoxvirus isolated from sheep origin grouped under Sheeppox cluster and those isolated from goats grouped under Goatpox cluster (Fig 2). The SPPV strain isolated in the present study was 100% identical with other SPPV strains within India reported from Pune, Tamil Nadu, Bareilly, Akola and even from foreign countries (Tunisia). Interestingly, the SPPV strain was also 100% identical to vaccine strains Srinagar and Rumanian-Fanar (RF). The GTPV closely identical (~98-99%) with other strains from India like Sambalpur and Mizoram and even foreign strains from China, but has some unique signatures of its own. Both the SPPV and GTPV were divergent from Lumpy Skin Disease (LSD) strains. The divergence and relatedness analysis of SPPV and GTPV isolates from Jammu in the present study showed 97.8% identity between the two isolates (Fig 3).
The capripoxviruses have a very large genome and there can be many potential gene targets for diagnosis. The usual choice for using the P32 protein encoding gene is because of its highly conserved nature across all CaPVs and its ability to detect both SPPV and GTPV. The enveloped structural protein contains major immunogenic determinants and therefore has been a preferred target for developing molecular diagnostic tools for detection and differentiation of Capripoxviruses by many workers (Ireland and Binepal, 1998;
Heine et al., 1999; Hosamani et al., 2004; Parthiban et al., 2005; Bhanuprakash et al., 2010). It is analogous to P35 protein of Vaccinia virus expressed on the envelope of the mature intracellular virion and may play a role in virus attachment, virulence and virus assembly
(Venkatesan et al., 2012). Partial or whole
P32 gene can be targeted with specific primers. Even when all CaPVs can be detected, differentiation with GTPV and SPPV can be possible with additional assays, like RFLP analysis
(Hosamani et al., 2004; Yan et al., 2010) or by sequence alignment of a part or whole genome of CaPV.
The present results show that there was a high and accurate degree of confirmatory diagnosis based on clinical signs and gross lesions of the disease in both sheep and goats and substantiated by PCR. The application of this method for diagnosing directly from clinical samples is fairly easy and effective.
Although the clinical samples and virus isolates in the present study were segregated according to the host species of animal affected, yet a putative designation of GTPV and SPPV was only confirmed after a sequence alignment and phylogenetic construct of the amplified nucleotides. Although earlier reports from some of the areas (Samba district) showed mixed infection in sheep and goats during an outbreak in January 2013 with a GTPV isolate
(Ramakrishnan et al., 2016), the present study however demonstrated host specificity of the CaPVs. This has also been substantiated clinically when only either sheep or goats were affected, even when flocks were co-populated with both animal species. Moreover, sequence alignment showed that
Capripoxvirus isolated from either animal species clustered under their respective genogroups. However, the possibility of cross transmission cannot be overruled.
Based on the
P32 gene, the SPPV isolate shared nucleotide sequence homology with many Indian isolates and some foreign ones. However, homology with vaccine strains makes differentiation between vaccine and field strains difficult. The SPPV nucleotide sequence was 100% identical with both prevalent vaccine strains [Rumanian-Fanar (SPPV-RF) and Srinagar (SPPV-Srinagar) vaccine strains]. Such similarities are also reported for field SPPV isolates elsewhere in the country, either with SPPV-RF vaccine
(Hosamani et al., 2004) or SPPV-Ranipet vaccine strain
(Parthiban et al., 2005; Rajamuthu et al., 2009). The Rumanian-Fanar (RF) strain licensed and extensively used in India is attenuated from serial passage in primary lamb testes, while SPPV-Srinagar strain has been developed from a local isolate and attenuated in vero cells
(Yogisharadhya et al., 2011) and SPPV-Ranipet used in Tamil Nadu has been attenuated in ovine thyroid cells and lamb testes cells
(Bhanuprakash et al., 2004). The homology of the circulating Indian SPPV strains favours devising uniform control strategies throughout the country. Since the live attenuated SPPV have been used in enzootic areas, vaccination failure or vaccine induced diseases also cannot be ruled out.
The GTPV isolate although sharing nucleotide homology with other Indian isolates (~98-99%), yet there could be subtle differences in nucleotide or amino acid sequences. Earlier reports of such changes have been documented
(Santhamani et al., 2014; Ramakrishnan et al., 2016), including presence of an additional aspartic acid at 55
th position of
P32 of sheep poxvirus that is absent in both goat poxvirus and lumpy skin disease virus
(Hosamani et al., 2004). It is envisaged that any genetic changes or mutations in the viral envelope protein genes, such as the
P32 gene which is a major immunogenic protein
(Heine et al., 1999), could lead to alterations in the immunogenic properties of the virus. This could lead to vaccination failures when specific GTPV vaccine is not readily available in the country.